Clinical Research and Quality Assurance GCP CERTIFICATE PROGRAM Your Trusted Partners for Quality Assurance and Regulatory Services
CRQA Jobs
QA AUDITORS-Part Time / Project Basis – All Major Cities
CRQA – www.crqa.in is an upcoming clinical research quality assurance firm, established by the senior professionals from the clinical research and pharmaceutical industry.
CRQA is looking for QA and Auditing professionals on part time or assignment basis at various locations in India with auditing experience in the following areas:
  • GCP Audits
  • Clinical Operations
  • CRO Audits
  • Central Lab and Bio analytical Lab Audits
  • Clinical Trial Supply Audits
  • IRB Audits
  • System Audits
  • Data Management Audits
  • Essential Document Audits
  • Pharmacovigilance Audits
  • GLP / GMP Audits
  • SOP Development
  • Regulatory Inspections Preparations
KEY RESPONSIBILITIES
  • Perform QA audits of clinical trial data and records in order to assure compliance with client SOPs, study protocols, GCP guidelines, relevant regulations and ISO 9000 requirements.
  • Plan and conduct regular and random QA audits.
  • Perform quality system audits and contract audits for Sponsors.
  • Ensure that audit results are formally recorded and reported and that corrective/preventive actions are documented.
  • As an auditor, perform the duties assigned in an efficient and effective manner. This includes liaison with the sponsors on all QA issues, including audit planning and review of audit results.
  • QA Training.
QUALIFICATION & EXPERIENCE
  • Qualification in medicine, science and/or other relevant discipline and appropriate experience.
  • Previous experience in Quality Assurance auditing – 2 – 5 years.
  • Detailed knowledge of GCP guidelines and relevant regulations for the conduct of clinical trials.
  • Ability to review and evaluate clinical data / records.
  • Excellent communication and interpersonal skills.
These are part time / project assignment based positions. Only apply if you are interested in working on part time / project basis. Kindly apply in confidence with your detailed CV detailing your QA / Audit experience to bd@crqa.in – www.crqa.in.
What's New
Clinical Trial Inspections
Guidelines & procedures for planning, conducting & reporting of inspection of sponsor/ CROs, clinical trial site defined in proposed Schedule Y2

www.pharmabiz.com
EC registration
Requirements & Guidelines for registration of Ethics committees defined in proposed Schedule Y3 Mandatory criteria, record keeping & information required for registration is described Guidelines cover all ECs who review & accord their approval to a clinical trial protocol
DCGI set to form committees to formulate guidelines for Good Distribution Practices
Drugs Controller General of India (DCGI) will be setting up a committee to oversee the formulation of guidelines for the Good Distribution Practices(GDP). The decision was taken at a recently held meeting state drugs controllers.

Although the agenda was to discuss the regulations in medical devices, clinical trials and fixed drug combinations, the focus of the meet was on the need to amend the Drugs and Cosmetics Act with the addition of new schedule on Good Distribution Practices.

www.pharmabiz.com
New code for inspecting human drug trials:
Guidelines to specify who will conduct inspection, how it will be conducted and the documents required.

www.livemint.com
Clinical Trials in India:
Times of India 29th Nov.10
As per study done by Centre for studies Ethics and Rights, Mumbai and published in The Indian Journal of Medical Ethics the number of Clinical Trials is growing at 36% annually, from 2006 to 2010.The study reveals that most trials by foreign sponsor and Pharmaceutical companies are for Cancer and Circulatory System related Diseases and conducted in cities and states like Mumbai, Pune, Bangalore and Hyderabad in which Mumbai and Pune account for largest number of trials conducted in the Country.
DCGI Inspection Start Soon
Central Drug Standard Control Organization (CDSCO) today indicated for the start of a routine course of Regulatory Inspections in India. According to Drug Controller General of India (DCGI) Dr Surinder Singh the Inspections will be carried out by USFDA trained people which will assure us of the quality of data generated which will be acceptable globally and also about the volunteers safety. The notification regarding the same shall be made public within a couple of days. After the registry of clinical trials conducted in India made mandatory in 2009, the next move is registration of CRO’s.